News Updates
Scope
Catalyst

Thu, Jun 4, 2026

1 updates
GUTS
7:00 AM

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation and a single Revita procedure 5.3% mean weight change observed with Revita (n=15); published third-party studies after GLP-1 withdrawal alone have shown ~15% weight regain at similar time points 33% of

Trial ResultsREVEAL-1 one-year results Thu, Jun 4, 2026fractyl.com

Tue, May 12, 2026

1 updates
GUTS
4:05 PM

Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates

Next anticipated Revita ® clinical data readouts are 1-year data from the REVEAL-1 Cohort in Q2 2026 and 1-year randomized data from the REMAIN-1 Midpoint Cohort in Q3 2026 Early Q4 2026 timing for topline 6-month randomized data from the REMAIN-1 Pivotal Cohort and late Q4 2026 timing for

Trial Results • Phase 2/3REMAIN-1 Pivotal Cohort topline data Thu, Oct 1, 2026, 4:30 PM ETfractyl.com